759316

    544578

    RUBICON

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Rubicon Research Limited Share Price Today

    RUBICON RESEARCH LIMITED is currently trading at ₹1439.6, up by ₹20.59 from the previous close. During the latest trading session, the stock touched an intraday high of ₹1449.00 and a low of ₹1390.30. Over the past six months, RUBICON RESEARCH LIMITED has delivered a return of 129.16%, while the stock has gained 5.21% in the last one month.

    Rubicon Research Limited performance

    Today’s low Today’s high
    ₹ 1390.30 ₹ 1449.00
    ₹ 1439.60
    52 week low 52 week high
    ₹ 570.75 ₹ 1527.00
    ₹ 1439.60
    Open Price ₹ 1415.20
    Prev. Close ₹ 1419.00
    Volume (Shares) 214186.00
    Total traded value ₹ 3083.42
    Upper Circuit ₹ 1702.80
    Lower Circuit ₹ 1135.20
    info

    Investment Returns

    Over 1 Month 5.21% Over 3 Months 60.15% Over 6 Months 117.00% Over 1 Year 129.16%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Rubicon Research Limited fundamentals


    • Market cap (Cr) 23,808.50
    • P/E Ratio (TTM) 126.56
    • Beta 0.43
    • Book Value / share 81.82
    • Return on equity 29.30%
    • EPS (TTM) 11.38
    • Dividend yield 0.10%
    • Net profit/quarter (Cr) 70.02
    info icon alternate text
    • Market cap (Cr) 23,818.40
    • P/E Ratio (TTM) 126.56
    • Beta 0.38
    • Book Value / share 81.82
    • Return on equity 29.30%
    • EPS (TTM) 11.38
    • Dividend yield 0.10%
    • Net profit/quarter (Cr) 70.02
    info icon alternate text

    Rubicon Research Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 389.88
    Operating Expense 299.28
    Net Profit 70.02
    Net Profit Margin (%) 17.95
    Earnings Per Share (EPS) 4.25
    EBITDA 109.76
    Effective Tax Rate (%) 25.66
    Particulars DEC 2025 (Values in Cr)
    Revenue 301.71
    Operating Expense 256.49
    Net Profit 37.18
    Net Profit Margin (%) 12.32
    Earnings Per Share (EPS) 2.28
    EBITDA 66.55
    Effective Tax Rate (%) 24.93
    Particulars SEP 2025 (Values in Cr)
    Revenue 336.47
    Operating Expense 276.34
    Net Profit 45.81
    Net Profit Margin (%) 13.61
    Earnings Per Share (EPS) 2.97
    EBITDA 80.62
    Effective Tax Rate (%) 25.66
    Particulars JUN 2025 (Values in Cr)
    Revenue 278.03
    Operating Expense 232.03
    Net Profit 35.15
    Net Profit Margin (%) 12.64
    Earnings Per Share (EPS) 2.28
    EBITDA 64.59
    Effective Tax Rate (%) 25.88
    Particulars MAR 2025 (Values in Cr)
    Revenue 300.81
    Operating Expense 258.84
    Net Profit 40.27
    Net Profit Margin (%) 13.38
    Earnings Per Share (EPS) 2.64
    EBITDA 73.28
    Effective Tax Rate (%) 25.32
    Particulars MAR 2026 (Values in Cr)
    Revenue 1306.08
    Operating Expense 1064.14
    Net Profit 188.17
    Net Profit Margin (%) 14.40
    Earnings Per Share (EPS) 11.83
    EBITDA 321.49
    Effective Tax Rate (%) 25.55
    Particulars MAR 2025 (Values in Cr)
    Revenue 1073.84
    Operating Expense 870.25
    Net Profit 167.54
    Net Profit Margin (%) 15.60
    Earnings Per Share (EPS) 11.00
    EBITDA 289.58
    Effective Tax Rate (%) 24.96
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 35.10
    ROE % 29.02
    ROCE % 25.02
    Total Debt to Total Equity 0.91
    EBITDA Margin 20.86
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 25.31
    ROE % 27.11
    ROCE % 18.42
    Total Debt to Total Equity 1.11
    EBITDA Margin 20.27
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 564.84
    ROE % -5.71
    ROCE % 1.45
    Total Debt to Total Equity 0.84
    EBITDA Margin 11.17
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 602.36
    ROE % -19.75
    ROCE % -11.80
    Total Debt to Total Equity 0.39
    EBITDA Margin -7.14
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 737.96
    ROE % 8.59
    ROCE % 17.01
    Total Debt to Total Equity 0.17
    EBITDA Margin 32.35
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 43.33
    ROE % 29.30
    ROCE % 26.05
    Total Debt to Total Equity 0.72
    EBITDA Margin 26.97
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 31.29
    ROE % 6.39
    ROCE % 8.61
    Total Debt to Total Equity 0.96
    EBITDA Margin 15.79
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 564.84
    ROE % -4.72
    ROCE % 1.31
    Total Debt to Total Equity 0.68
    EBITDA Margin 11.17
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 845.39
    ROE % 3.97
    ROCE % 4.68
    Total Debt to Total Equity 0.31
    EBITDA Margin 14.36
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 811.56
    ROE % 13.81
    ROCE % 21.00
    Total Debt to Total Equity 0.16
    EBITDA Margin 36.86
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 116.23
    Total Assets 1451.43
    Total Liabilities 1451.43
    Total Equity 540.98
    Share Outstanding 15
    Price to Book Ratio 0.00
    Return on Assets (%) 9.25
    Return on Capital (%) 14.38
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 58.39
    Total Assets 1109.48
    Total Liabilities 1109.48
    Total Equity 385.00
    Share Outstanding 15
    Price to Book Ratio 0.00
    Return on Assets (%) 8.20
    Return on Capital (%) 11.65
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 58.91
    Total Assets 749.70
    Total Liabilities 749.70
    Total Equity 286.37
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -2.25
    Return on Capital (%) -2.79
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 52.60
    Total Assets 559.51
    Total Liabilities 559.51
    Total Equity 305.39
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -11.99
    Return on Capital (%) -14.13
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 85.98
    Total Assets 538.25
    Total Liabilities 538.25
    Total Equity 374.14
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 5.70
    Return on Capital (%) 6.73
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 37.10
    Total Assets 1340.93
    Total Liabilities 1340.93
    Total Equity 667.78
    Share Outstanding 15
    Price to Book Ratio 0.00
    Return on Assets (%) 12.49
    Return on Capital (%) 15.79
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 48.25
    Total Assets 1016.59
    Total Liabilities 1016.59
    Total Equity 475.86
    Share Outstanding 15
    Price to Book Ratio 0.00
    Return on Assets (%) 2.39
    Return on Capital (%) 2.79
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 58.91
    Total Assets 749.70
    Total Liabilities 749.70
    Total Equity 286.37
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -2.25
    Return on Capital (%) -2.79
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 43.50
    Total Assets 678.33
    Total Liabilities 678.33
    Total Equity 428.61
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 2.45
    Return on Capital (%) 2.79
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 78.64
    Total Assets 569.59
    Total Liabilities 569.59
    Total Equity 411.46
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 9.29
    Return on Capital (%) 10.5
    Particulars MAR 2025 (Values in Cr)
    Net Income 194.52
    Cash from Operations 197.92
    Cash from Investing -64.80
    Cash from Financing -39.81
    Net change in Cash 54.55
    Free Cash Flow 268.15
    Particulars MAR 2024 (Values in Cr)
    Net Income 102.85
    Cash from Operations 39.08
    Cash from Investing -68.51
    Cash from Financing 43.55
    Net change in Cash -3.95
    Free Cash Flow 95.22
    Particulars MAR 2023 (Values in Cr)
    Net Income -11.04
    Cash from Operations -72.92
    Cash from Investing -33.82
    Cash from Financing 122.81
    Net change in Cash 14.24
    Free Cash Flow -28.46
    Particulars MAR 2022 (Values in Cr)
    Net Income -66.11
    Cash from Operations -54.16
    Cash from Investing -54.92
    Cash from Financing 63.05
    Net change in Cash -54.50
    Free Cash Flow 0.33
    Particulars MAR 2021 (Values in Cr)
    Net Income 63.12
    Cash from Operations 95.11
    Cash from Investing -46.09
    Cash from Financing 51.50
    Net change in Cash 67.08
    Free Cash Flow 166.39
    Particulars MAR 2025 (Values in Cr)
    Net Income 223.27
    Cash from Operations 56.50
    Cash from Investing -10.03
    Cash from Financing -34.04
    Net change in Cash -14.43
    Free Cash Flow 126.97
    Particulars MAR 2024 (Values in Cr)
    Net Income 34.07
    Cash from Operations 99.08
    Cash from Investing -130.48
    Cash from Financing 45.86
    Net change in Cash -1.42
    Free Cash Flow 155.00
    Particulars MAR 2023 (Values in Cr)
    Net Income -11.04
    Cash from Operations -72.92
    Cash from Investing -33.82
    Cash from Financing 122.81
    Net change in Cash 14.24
    Free Cash Flow -28.46
    Particulars MAR 2022 (Values in Cr)
    Net Income 16.92
    Cash from Operations -61.51
    Cash from Investing -52.21
    Cash from Financing 65.22
    Net change in Cash -49.07
    Free Cash Flow -61.51
    Particulars MAR 2021 (Values in Cr)
    Net Income 85.38
    Cash from Operations 81.14
    Cash from Investing -31.63
    Cash from Financing 52.17
    Net change in Cash 70.14
    Free Cash Flow 81.14
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.96 12.85 1.49 237.26 23.12 38.85
    BLISS GVS PHARMA LTD. 482.50 38.79 4.28 5117.21 118.35 552.90
    CIPLA LTD 1418.40 30.10 3.32 114584.78 1165.55 1672.20
    FERMENTA BIOTECH LTD. 431.50 19.03 3.12 1269.95 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.96 21.65 3.98 237.26 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 537.90 24.11 4.20 1555.10 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8025.95 104.82 22.98 20064.88 7630.00 9850.00
    BLISS GVS PHARMA LTD. 482.50 52.16 4.42 5117.21 118.35 552.90

    Rubicon Research Limited shareholding pattern

    Holding
    22.58%
    59.86%
    7.53%
    10.01%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    Rubicon Research Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1439.60 1.45 redarrow
    red-green-graph indicator
    1 Bearish
    15 Bullish
    • 5 Days 1436.40
    • 26 Days 1358.50
    • 10 Days 1423.00
    • 50 Days 1251.20
    • 12 Days 1416.60
    • 100 Days 1089.90
    • 20 Days 1385.30
    • 200 Days 862.00
    1429.83 PIVOT
    First Support 1384.67 First Resistance 1464.17 Second Support 1350.33 Second Resistance 1509.33 Third Support 1305.17 Third Resistance 1543.67
    RSI 61.38 ADX 29.59 MACD 58.05 Williams % R -36.31 Commodity Channel Index (CCI) 55.95
    Date 2026-07-17 Week 118172.00 Same Day 103962.00 Month 121867.00
    1 Year 0.43 3 Year 0.41
    Over 1 Month
    5.21% down
    Over 1 Year
    129.16% down
    Over 3 Months
    60.15% down
    Over 3 Years
    0.00% down
    Over 6 Months
    117.00% down
    Over 5 Years
    0.00% down

    Rubicon Research Limited Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Rubicon Research Ltd?

    Answer Field

    Rubicon Research Ltd share price is for NSE ₹ 1,439.60 & for BSE ₹ 1,438.95 as on Jul 17 2026 03:30 PM.

    What is the Market Cap of Rubicon Research Ltd Share?

    Answer Field

    The market cap of Rubicon Research Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 17 2026 03:30 PM.

    What is the 52 Week High and Low of Rubicon Research Ltd?

    Answer Field

    The 52 Week High and Low of Rubicon Research Ltd for NSE is ₹ 1,527.00 and ₹ 570.75 and for BSE is ₹ 1,525.25 and ₹ 571.00.

    What is 1 year return for Rubicon Research Ltd?

    Answer Field

    The 1 year returns on the stock has been 129.16%.

    What is the P/E Ratio of Rubicon Research Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM the price-to-earnings (PE) ratio for Rubicon Research Ltd share is 126.56.

    What is the PB ratio of Rubicon Research Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM, the price-to-book (PB) ratio for Rubicon Research Ltd share is 81.82.

    How to Buy Rubicon Research Ltd Share?

    Answer Field

    You can trade in Rubicon Research Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Rubicon Research Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Rubicon Research Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Rubicon Research Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |